after ex parte appeal
on 31 Jan 2023
Last Applicant/ Owned by
1075 Skyler Drive
Draper
UT
84020
Serial Number
87429006 filed on 20th Dec 2018
Registration Number
N/A
Correspondent Address
WOODROW H POLLACK
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIOAVAILABILITY"
"BIOAVAILABILITY" TOTAL BIO TOTAL BIO AVAILABILITY Pharmaceuticals, for the regulation of body systems, namely, for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; theRead More
Pharmaceuticals, for the regulation of body systems, namely, for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; therapeutics for health and well-being, namely, pharmaceuticals, sprays, agents, edibles in the nature of pills and tablets for the treatment of conditions such as weight control, appetite suppression, muscle relaxation, sleep disorders; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3% on a dry weight basis
No 87429006
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 31st Jan 2023 | EXPARTE APPEAL TERMINATED |
| 31st Jan 2023 | ABANDONMENT - AFTER EX PARTE APPEAL |
| 31st Jan 2023 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
| 17th Nov 2022 | EX PARTE APPEAL-REFUSAL AFFIRMED |
| 17th Dec 2021 | EXAMINERS STATEMENT - COMPLETED |
| 17th Dec 2021 | EXAMINERS STATEMENT E-MAILED |
| 17th Dec 2021 | NOTIFICATION OF EXAMINERS STATEMENT E-MAILED |
| 29th Oct 2021 | ASSIGNED TO EXAMINER |
| 26th Oct 2021 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| 17th May 2021 | SUBSEQUENT FINAL REFUSAL WRITTEN |
